HIF1A and cancer: In addition to NF-κB and STAT3, astragaloside IV could regulate the expression of various signal pathways and growth factors, such as VEGF, Nrf2, HIF-1α, P13k-AKT, etc.51, which were closely related to cancer progression, suggesting that astragaloside IV was a promising anticancer drug.